354 related articles for article (PubMed ID: 23588704)
21. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
22. Use of antipsychotics in children and adolescents.
Findling RL; Steiner H; Weller EB
J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
[TBL] [Abstract][Full Text] [Related]
23. Treatment of bipolar mania with atypical antipsychotics.
Chengappa KN; Suppes T; Berk M
Expert Rev Neurother; 2004 Nov; 4(6 Suppl 2):S17-25. PubMed ID: 16279862
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of paliperidone ER and other oral atypical antipsychotics in schizophrenia.
Jones MP; Nicholl D; Trakas K
Int J Clin Pharmacol Ther; 2010 Jun; 48(6):383-99. PubMed ID: 20497747
[TBL] [Abstract][Full Text] [Related]
25. Antipsychotic drug toxicology in children.
Caccia S; Clavenna A; Bonati M
Expert Opin Drug Metab Toxicol; 2011 May; 7(5):591-608. PubMed ID: 21401439
[TBL] [Abstract][Full Text] [Related]
26. A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics.
Lee ES; Vidal C; Findling RL
J Child Adolesc Psychopharmacol; 2018 Nov; 28(9):582-605. PubMed ID: 30312108
[TBL] [Abstract][Full Text] [Related]
27. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
[TBL] [Abstract][Full Text] [Related]
28. Off-label second generation antipsychotics for impulse regulation disorders: a review.
Scheltema Beduin A; de Haan L
Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
[TBL] [Abstract][Full Text] [Related]
29. Management of schizophrenia in children and adolescents: focus on pharmacotherapy.
Masi G; Liboni F
Drugs; 2011 Jan; 71(2):179-208. PubMed ID: 21275445
[TBL] [Abstract][Full Text] [Related]
30. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
Maayan L; Correll CU
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
[TBL] [Abstract][Full Text] [Related]
31. Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.
Stigler KA; Potenza MN; Posey DJ; McDougle CJ
Paediatr Drugs; 2004; 6(1):33-44. PubMed ID: 14969568
[TBL] [Abstract][Full Text] [Related]
32. [Prescription of olanzapine in children and adolescent psychiatric patients].
Frémaux T; Reymann JM; Chevreuil C; Bentué-Ferrer D
Encephale; 2007; 33(2):188-96. PubMed ID: 17675914
[TBL] [Abstract][Full Text] [Related]
33. Atypical antipsychotic agents: a critical review.
Worrel JA; Marken PA; Beckman SE; Ruehter VL
Am J Health Syst Pharm; 2000 Feb; 57(3):238-55. PubMed ID: 10674777
[TBL] [Abstract][Full Text] [Related]
34. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
35. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.
Citrome L; Holt RI; Walker DJ; Hoffmann VP
Clin Drug Investig; 2011; 31(7):455-82. PubMed ID: 21495734
[TBL] [Abstract][Full Text] [Related]
36. Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis.
Gentile S
Drug Saf; 2006; 29(4):303-19. PubMed ID: 16569080
[TBL] [Abstract][Full Text] [Related]
37. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
Swainston Harrison T; Perry CM
Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
[TBL] [Abstract][Full Text] [Related]
38. Safety and tolerability of antipsychotic treatment in young patients with schizophrenia.
Correll CU
J Clin Psychiatry; 2011 Aug; 72(8):e26. PubMed ID: 21899814
[TBL] [Abstract][Full Text] [Related]
39. Paliperidone for schizophrenia.
Dolder C; Nelson M; Deyo Z
Am J Health Syst Pharm; 2008 Mar; 65(5):403-13. PubMed ID: 18281731
[TBL] [Abstract][Full Text] [Related]
40. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.
Mauri MC; Volonteri LS; Colasanti A; Fiorentini A; De Gaspari IF; Bareggi SR
Clin Pharmacokinet; 2007; 46(5):359-88. PubMed ID: 17465637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]